Cergutuzumab (Anti-CEACAM5 / CEA / CD66e)

Cergutuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanized monoclonal antibody which targets Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) with immunostimulating and antineoplastic activities. MW : 146.48 KD.

• Supplier: Selleck Chemicals
• Product #: A2841
• Sku #: A2841-1mg